Showing results (1361-1370 of 2,021) with videos related to

Sort By:
Pageof 203
Annals of Hepatology|December 30, 2019
48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patientsLi Gao, Yue Hu, Xiaofeng Shi, et al.
Annals of Hepatology|September 21, 2020
COVID-19 and the liver: What do we know after six months of the pandemic?Nora A Fierro
Annals of Hepatology|September 27, 2020
Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signalingShuxia Tian, Min Chen, Bing Wang, et al.
Annals of Hepatology|September 28, 2020
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseasesTomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, et al.
Annals of Hepatology|October 2, 2020
Temporal histopathological changes in biliary atresia: A perspective for rapid fibrosis progressionHanaa A El-Araby, Magdy A Saber, Noha M Radwan, et al.
Annals of Hepatology|November 15, 2020
Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort studyDongying Zhao, Xiaohui Gong, Yahui Li, et al.
Annals of Hepatology|December 21, 2020
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5pJingjing Yao, Jindong Fu, Ying Liu, et al.
Annals of Hepatology|October 15, 2020
Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5pYing Yao, Fang Shu, Fang Wang, et al.
Annals of Hepatology|July 5, 2022
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trialsMohamed Abdallah, Landon Brown, John Provenza, et al.
Annals of Hepatology|January 30, 2021
Horizon scanning of therapeutic modalities for nonalcoholic steatohepatitisChanthawat Patikorn, Sajesh K Veettil, Pochamana Phisalprapa, et al.
Pageof 203